...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >COMPRATIVE ANTIMICROBIAL EFFICACY EVALUATION OF A NEW PRODUCT ELORES AGAINST MEROPENEM ON GRAM NEGATIVE ISOLATES
【24h】

COMPRATIVE ANTIMICROBIAL EFFICACY EVALUATION OF A NEW PRODUCT ELORES AGAINST MEROPENEM ON GRAM NEGATIVE ISOLATES

机译:革兰氏阴性分离物抗美罗培南新产品的比较抗微生物功效评估

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and objective: Increased resistance of Gram-negative bacteria towards most of the available antibiotics, especially beta-lactamantibiotics is a prime difficulty for the treatment of infections caused by these pathogens. In view of the fact that there is a continuous increase in theantibitic resistance and the limited available therapeutic options, we aimed the present work to evaluate the antibiotic susceptibility pattern of 847isolates towards meropenem and Elores (ceftriaxone+sulbcatam+and adjuvant ethylenediaminetetraacetic acid).Methods: A total of 1180 clinical samples were collected from patients suspected of bacterial infection between January 2014 to June 2014. Thesesamples were subjected for bacterial identification. Antibiotic susceptibility testing were carried out according to the recommendations of ClinicalLaboratory Standards Institute (CLSI) guidelines.Results: Among the samples which showed the presence of bacteria, around 29.04% samples were of sputum followed by urine and blood whichcontributed to 21.95% and 12.51%, respectively. Escherichia coli (39.55%) was found to be the most dominant pathogen, followed by Pseudomonasaeruginosa (19.12%), Klebsiella pneumoniae (12.39%), Proteus mirabilis (8.50%), Klebsiella oxytoca (8.26%), Acinetobacter baumannii (5.31%),Morganella morganii (3.77%), Serratia marcescens (2.24%). The susceptibility of Elores was comparable with meropenem in some of the organisms,but Elores displayed higher susceptibility in E. coli, A. baumannii, K. pneumoniae, P. mirabilis, K. oxytoca, M. morganii and S. mercescens which might bedue to presence of metallo-beta lactamases in these isolates.Conclusion: Overall, the results of this study strongly advocate the equivalance of Elores with meropenem and can be of very effective alternative totreat against the deadly multi drug resistant Gram-negative bacteria.
机译:背景与目的:革兰氏阴性细菌对大多数可用抗生素(尤其是β-内酰胺类抗生素)的耐药性增加是治疗由这些病原体引起的感染的主要困难。鉴于抗药性的持续增加和有限的可用治疗方法,我们针对目前的工作来评估847菌株对美罗培南和Elores(头孢曲松+舒巴坦+辅助乙二胺四乙酸)的抗生素敏感性模式。 :从2014年1月至2014年6月,从疑似细菌感染的患者中收集了1180份临床样本。这些样本用于细菌鉴定。结果:在显示细菌存在的样本中,约有29.04%的样本是痰,其次是尿液和血液,分别占21.95%和12.51%。 , 分别。大肠杆菌(39.55%)被发现是最主要的病原体,其次是假单胞菌铜绿假单胞菌(19.12%),肺炎克雷伯菌(12.39%),奇异变形杆菌(8.50%),产氧克雷伯菌(8.26%),鲍曼不动杆菌(5.31%) ,摩根氏摩根氏菌(3.77%),粘质沙雷氏菌(2.24%)。在某些微生物中,Elores的敏感性与美罗培南相当,但Elores在大肠杆菌,鲍曼不动杆菌,肺炎克雷伯氏菌,奇异毕赤酵母,产氧克雷伯氏菌,摩根氏支原体和梅花链球菌中表现出较高的敏感性。结论:总体而言,这项研究的结果强烈主张与美罗培南等同于Elores,并且可以作为治疗致命的多药耐药革兰氏阴性细菌的有效替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号